Your browser doesn't support javascript.
loading
Interleukin 6 (IL6) level is a biomarker for functional disease progression within IL6R358Ala variant groups in amyotrophic lateral sclerosis patients.
Wosiski-Kuhn, Marlena; Caress, James B; Cartwright, Michael S; Hawkins, Gregory A; Milligan, Carol.
Afiliación
  • Wosiski-Kuhn M; Department of Neurobiology and Anatomy, Wake Forest School of Medicine, Winston-Salem, NC, USA.
  • Caress JB; Department of Neurology, Wake Forest School of Medicine, Winston-Salem, NC, USA, and.
  • Cartwright MS; Department of Neurology, Wake Forest School of Medicine, Winston-Salem, NC, USA, and.
  • Hawkins GA; Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC, USA.
  • Milligan C; Department of Neurobiology and Anatomy, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Article en En | MEDLINE | ID: mdl-32924606

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interleucina-6 / Esclerosis Amiotrófica Lateral Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Amyotroph Lateral Scler Frontotemporal Degener Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interleucina-6 / Esclerosis Amiotrófica Lateral Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Amyotroph Lateral Scler Frontotemporal Degener Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido